Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients With Relapsing Multiple Sclerosis (MS)

This study has been completed.

Study NCT00079495 Information provided by Neurocrine Biosciences

First Received: March 8, 2004 Last Updated: March 20, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	April 2005
Estimated Primary Completion Date:	No date given